Episode 2 of Demystifying NMO by The Sumaira Foundation (TSF) for NMO and Connor B Judge Foundation (CBFJ) focuses on NMO Treatments: Acute vs Maintenance. Follow along to hear a candid conversation between Connor, of the CBJF and NMO patient, and his sister Chelsey, also scientific advisor with the CBJF. In their discussion, they talk about the differences in treatments to manage an active relapse versus to help prevent relapse.

Glossary of Terms Used

AQP4: aquaporin-4; a water channel protein found in the CNS; antibodies can be made against this in NMOSD patients

B-cell: a white blood cell that is a key component of the adaptive immune system and makes antibodies

Immunosuppressant: a medication that reduces/supresses the function of some immune system component

MOG: myelin-oligodendrocyte glycoprotein; a myelin protein; antibodies can be made against this in some NMOSD patients

Relapse: clinical disease activity/clinical worsening